/
Navigation
Chronicles
Browse all articles
Explore
Semantic exploration
Research
Entity momentum
Nexus
Correlations & relationships
Story Arc
Topic evolution
Drift Map
Semantic trajectory animation
Posts
Analysis & commentary
Pulse API
Tech news intelligence API
Browse
Entities
Companies, people, products, technologies
Domains
Browse by publication source
Handles
Browse by social media handle
Detection
Concept Search
Semantic similarity search
High Impact Stories
Top coverage by position
Sentiment Analysis
Positive/negative coverage
Anomaly Detection
Unusual coverage patterns
Analysis
Rivalry Report
Compare two entities head-to-head
Semantic Pivots
Narrative discontinuities
Crisis Response
Event recovery patterns
Connected
Search: /
Command: ⌘K
Embeddings: large
TEXXR

Chronicles

The story behind the story

← → days · ↑ ↓ browse · Enter similar · o open

Sleep apnea device maker ResMed agrees to sell its software business MatrixCare to PE firm Frazier for $490M in cash; ResMed bought MatrixCare for $750M in 2018

ResMed (RMD.N) said on Tuesday it would sell its software business MatrixCare to private equity firm Frazier Healthcare Partners …

Reuters Puyaan Singh

Context & Ripple Effects

ResMed’s MatrixCare exit reverses a 2018 expansion into cloud-based electronic health records, part of a period in which the sleep-device company also bought Propeller Health to add connected-care capabilities.

The coverage also shows healthcare software assets changing hands through private equity, including IBM’s Watson Health divestiture. MatrixCare’s move places a former strategic acquisition under a specialist financial owner instead.

First-order effects

  • ResMed will receive $490 million in cash and separate MatrixCare from its operating portfolio; Frazier Healthcare Partners becomes the business’s owner.
  • MatrixCare’s customers, products, and staff move from a sleep-apnea equipment maker to a healthcare-focused private-equity platform.

Second-order effects

  • ResMed can concentrate its capital and management attention on its remaining equipment and software businesses, including the connected-care capabilities it added through Propeller Health.
  • Under Frazier, MatrixCare may be managed as a standalone healthcare-software asset rather than as one component of ResMed’s broader device-and-software strategy, changing its priorities for partnerships and investment.

Third-order effects

  • The transaction adds to evidence that strategic buyers are reassessing earlier healthcare-software acquisitions while private equity remains a buyer of established health-tech assets.
  • If such divestitures continue, healthcare software could become more segmented between device makers focused on tightly linked digital services and PE-backed vendors serving broader provider workflows.

The trend: Healthcare technology portfolios are being reshaped as operating companies narrow around core platforms and private equity acquires software businesses carved out of larger strategic owners.

Discussion

  • @filapek Rudi Filapek-Vandyck on x
    RBC Capital on ResMed $RMD: “Since COVID the MatrixCare business has underperformed and management had been undertaking a strategic review of its Residential Care Software business, so today's announcement to sell MatrixCare does not come as a surprise. “However the sale price